...trial evaluate intratumoral and subcutaneous injections of HVJ-E in 12 CRPC patients. In 2009, AnGes' GenomIdea Inc....

...AnGes' GenomIdea Inc. subsidiary and TSD will jointly search for new partners to aid in the global...
...in the global development and commercialization of cancer candidate GEN0101 / TSD-0014 (HJV-E). In 2009, GenomIdea...

...Vical and AnGes' GenomIdea Inc. subsidiary partnered to develop a DNA vaccine using Vical's Vaxfectin adjuvant against...
...develop a DNA vaccine using Vical's Vaxfectin adjuvant against pandemic influenza for use in livestock. GenomIdea...
...the resulting livestock vaccine. Funding will be provided by the Okinawa Industry Promotion Public Corp. GenomIdea's...